IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v10y2019i1d10.1038_s41467-019-09312-9.html
   My bibliography  Save this article

Multiple ABCB1 transcriptional fusions in drug resistant high-grade serous ovarian and breast cancer

Author

Listed:
  • Elizabeth L. Christie

    (Peter MacCallum Cancer Centre
    The University of Melbourne)

  • Swetansu Pattnaik

    (Garvan Institute for Medical Research)

  • Jessica Beach

    (Peter MacCallum Cancer Centre)

  • Anthony Copeland

    (Peter MacCallum Cancer Centre)

  • Nineveh Rashoo

    (Peter MacCallum Cancer Centre)

  • Sian Fereday

    (Peter MacCallum Cancer Centre)

  • Joy Hendley

    (Peter MacCallum Cancer Centre)

  • Kathryn Alsop

    (Peter MacCallum Cancer Centre)

  • Samuel L. Brady

    (The University of Utah)

  • Greg Lamb

    (The University of Utah)

  • Ahwan Pandey

    (Peter MacCallum Cancer Centre)

  • Anna deFazio

    (The Westmead Institute for Medical Research
    Westmead Hospital
    The University of Sydney)

  • Heather Thorne

    (Peter MacCallum Cancer Centre)

  • Andrea Bild

    (The University of Utah
    City of Hope)

  • David D. L. Bowtell

    (Peter MacCallum Cancer Centre
    The University of Melbourne
    Garvan Institute for Medical Research)

Abstract

ABCB1 encodes Multidrug Resistance protein (MDR1), an ATP-binding cassette member involved in the cellular efflux of chemotherapeutic drugs. Here we report that ovarian and breast samples from chemotherapy treated patients are positive for multiple transcriptional fusions involving ABCB1, placing it under the control of a strong promoter while leaving its open reading frame intact. We identified 15 different transcriptional fusion partners involving ABCB1, as well as patients with multiple distinct fusion events. The partner gene selected depended on its structure, promoter strength, and chromosomal proximity to ABCB1. Fusion positivity was strongly associated with the number of lines of MDR1-substrate chemotherapy given. MDR1 inhibition in a fusion positive ovarian cancer cell line increased sensitivity to paclitaxel more than 50-fold. Convergent evolution of ABCB1 fusion is therefore frequent in chemotherapy resistant recurrent ovarian cancer. As most currently approved PARP inhibitors (PARPi) are MDR1 substrates, prior chemotherapy may precondition resistance to PARPi.

Suggested Citation

  • Elizabeth L. Christie & Swetansu Pattnaik & Jessica Beach & Anthony Copeland & Nineveh Rashoo & Sian Fereday & Joy Hendley & Kathryn Alsop & Samuel L. Brady & Greg Lamb & Ahwan Pandey & Anna deFazio &, 2019. "Multiple ABCB1 transcriptional fusions in drug resistant high-grade serous ovarian and breast cancer," Nature Communications, Nature, vol. 10(1), pages 1-10, December.
    • Handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-09312-9
    DOI: 10.1038/s41467-019-09312-9
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-019-09312-9
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-019-09312-9?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-09312-9. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.